London – Paul Hastings LLP, a leading global law firm, announced today that it has advised Jacobs Engineering Group Inc. on the acquisition of the patent rights for BAYQIK® quasi-isothermal sulfuric acid converter technology and other related technology from Bayer AG.

BAYQIK technology enables more efficient conversion of process gas with high SO2 concentrations. Bayer developed, piloted and commercialized the technology over the past 10 years. A full-scale installation based on the technology has operated successfully for seven years.

The Paul Hastings team was led by corporate partner Ronan O’Sullivan and senior associate Matthew Poxon in London, alongside partner Bernd Meyer-Witting and senior associate Florian Lechner in Frankfurt.